Aug 22, 2022
Reimagining R&D Webinar Series presenting “How FDA and Payers utilize RWE: Similarities and Differences.”
Vivpro Corporation has partnered with experts and industry leaders to discuss critical pharma and biotech topics. Our goal is to share valuable information and allow the audience to engage with questions while they receive real-time feedback.
For our August session, we are joined by Dr. Brigham Hyde, Ph.D., CEO of Atropos Health
Session Overview
Role of Real World Evidence (RWE) for regulatory decisions.
Role of RWE for payer decisions.
Case studies where RWE has played a pivotal role in regulatory decisions.
Key differences and similarities in the role of RWE.
About Dr. Brigham Hyde, Ph.D.
Brigham Hyde is CEO and co-founder of Atropos Health. He brings over 15 years of experience as an investor, operator, and entrepreneur in Health Tech and Data. He has served as President of Data and Analytics at Eversana and Chief Data Officer at DRG (exited to Clarivate 2020). He is a Stanford RWD spinout and holds advisory positions in multiple Data and Digital health tech ventures. Brigham received a Ph.D. in Clinical Pharmacology from Tufts University School of Medicine.
